Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 11 Rectal Neoplasms 4 Colorectal Cancer Metastatic 4 Colonic Neoplasms 3 Uterine Cervical Neoplasms 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Elderly Metastatic Colorectal Cancer Patients 1 Efficacy 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 10 Paclitaxel 9 Radiotherapy 5 Fluorouracil 5 Radiotherapy, Intensity-Modulated 4 Docetaxel 4 Carboplatin 4 advexin 2 Therapeutics 2 Surveys and Questionnaires 2 Oxaliplatin 2 Leucovorin 2 Drug Therapy 2 Cetuximab 2 Afatinib 2 penpulimab 1 pembrolizumab 1 olaparib 1 niraparib 1 nimotuzumab 1 nedaplatin 1 durvalumab 1 daromun 1 camrelizumab 1 calcipotriene 1 atezolizumab 1 afamelanotide 1 TP protocol 1 Surgical Procedures, Operative 1 Radiotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Squamous Cell × Panitumumab × Clear all

NCT01129154 2010-08-30

PASCE

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Unknown

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡